BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGarry ME, Williams WA 2nd, McColley SA. The demographics of adverse outcomes in cystic fibrosis. Pediatr Pulmonol 2019;54 Suppl 3:S74-83. [PMID: 31715087 DOI: 10.1002/ppul.24434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Albon D, Van Citters AD, Ong T, Dieni O, Dowd C, Willis A, Sabadosa KA, Scalia P, Reno K, Oates GR, Schechter MS. Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors. J Cyst Fibros 2021;20 Suppl 3:49-54. [PMID: 34930543 DOI: 10.1016/j.jcf.2021.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
2 South K, George M, Sadeghi H, Piane V, Smaldone A. Moving up: Healthcare transition experiences of adolescents and young adults with cystic fibrosis. Journal of Pediatric Nursing 2022. [DOI: 10.1016/j.pedn.2022.03.007] [Reference Citation Analysis]
3 DiMango E, Simpson K, Menten E, Keating C, Fan W, Leu CS. Health Disparities among adults cared for at an urban cystic fibrosis program. Orphanet J Rare Dis 2021;16:332. [PMID: 34332588 DOI: 10.1186/s13023-021-01965-4] [Reference Citation Analysis]
4 Garcia B, Christon L, Gray S; MUSC Adult CF Program. In the south, if you give us lemons, we will make you lemonade. J Cyst Fibros 2020;19:842-3. [PMID: 32546432 DOI: 10.1016/j.jcf.2020.06.003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fitzgerald DA. Mini-symposium: Cystic fibrosis in the era of modulators (Part 1). Paediatric Respiratory Reviews 2022. [DOI: 10.1016/j.prrv.2022.04.001] [Reference Citation Analysis]
6 Shemie G, Nguyen MT, Wallenburg J, Ratjen F, Knoppers BM. The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada. J Pers Med 2021;11:382. [PMID: 34067090 DOI: 10.3390/jpm11050382] [Reference Citation Analysis]
7 Rueda-Nieto S, Mondejar-Lopez P, Mira-Escolano MP, Cutillas-Tolín A, Maceda-Roldán LA, Arense-Gonzalo JJ, Palomar-Rodríguez JA. Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry. Orphanet J Rare Dis 2022;17:222. [PMID: 35698092 DOI: 10.1186/s13023-022-02373-y] [Reference Citation Analysis]
8 Sontag MK, Miller JI, Mckasson S, Gaviglio A, Martiniano SL, West R, Vazquez M, Ren CL, Farrell PM, Mccolley SA, Kellar-guenther Y. Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United States. IJNS 2022;8:38. [DOI: 10.3390/ijns8030038] [Reference Citation Analysis]
9 Knoppers T, Cosquer M, Hagan J, Nguyen MT, Knoppers BM. “The Stakes Are Higher”- Patient and Caregiver Perspectives on Cystic Fibrosis Research and Personalized Medicine. Front Med 2022;9:841887. [DOI: 10.3389/fmed.2022.841887] [Reference Citation Analysis]
10 McGarry ME, Huang CY, Nielson DW, Ly NP. Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States. J Cyst Fibros 2021;20:424-31. [PMID: 33162303 DOI: 10.1016/j.jcf.2020.10.002] [Reference Citation Analysis]